Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. [electronic resource]
Producer: 20150813Description: 9909-13 p. digitalISSN:- 2476-762X
- Amoxicillin -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Bismuth -- therapeutic use
- Clarithromycin -- therapeutic use
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Gastritis -- drug therapy
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- drug effects
- Humans
- Lansoprazole -- therapeutic use
- Male
- Middle Aged
- Organometallic Compounds -- therapeutic use
- Probiotics -- therapeutic use
- Prognosis
- Prospective Studies
- Salicylates -- therapeutic use
- Thailand
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.